AstraZeneca has decided to halt its £200 million investment plan at its research center in Cambridge, a project that would have created approximately 1,000 jobs. This is the company's second major withdrawal from the UK in 2024, after it abandoned a £450 million investment in vaccine manufacturing in January. The decisions of pharmaceutical companies, including Merck & Co., are putting pressure on the British government in the context of maintaining attractiveness for investments in the pharmaceutical sector.
Sources
AstraZeneca suspendă o investiţie de 270 de milioane de dolari în Marea Britanie
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
AstraZeneca pauses £200m Cambridge investment
Britain’s biggest company AstraZeneca pauses £200m investment into Cambridge site
Latest News
23:03
Kallas says Usmanov and Fridman will not return to the EU list anytime soon, while sanctions on more than 3,000 individuals and entities are extended until 2029
22:56
Cristian Tudor Popescu: Luca Niculescu cannot form a government under the current political configuration
22:50
Iranian President Masoud Pezeshkian rejects negotiations with the US: “They make no sense”
22:49
Vladimir Putin approves the reorganization and sale of UniCredit’s Russian subsidiary
22:41
Moldova is gradually extending VAT and excise duties to goods brought in by operators from Transnistria as part of its economic reintegration strategy
See more news